STOCK TITAN

James Hardie Financials

JHX
FY2026 annual
Revenue $4.8B +24.7% YoY
Net Income $104.0M -75.5% YoY
EPS (Diluted) $0.19 -80.6% YoY
Free Cash Flow $205.9M -45.9% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE March

James Hardie (JHX) reported $4.8B in revenue for fiscal year 2026, up 24.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI JHX FY2026

Purchased scale reshaped James Hardie into a larger, more leveraged platform, but the new volume carries thinner earnings.

Last year, goodwill jumped from $194M to $4.78B, showing the expansion was purchased rather than built internally. That heavier structure left operating margin down to 9.3% as long-term debt reached $4.49B, so added scale arrived with lower earnings density.

Cash generation held up better than accounting profit: operating cash flow was $589.8M against net income of $104M, implying non-cash charges absorbed reported earnings more than they absorbed cash. Even so, free cash flow slipped to $205.9M after $383.9M of capital spending, so the larger company is not yet translating scale into abundant discretionary cash.

Short-term liquidity still looks workable at 1.6x, but balance-sheet risk shifted upward because total liabilities reached $7.26B and the asset base became far more acquisition-heavy. Returns show that strain: ROA fell from 8.1% to 0.8%, meaning the enlarged asset base generated far less profit per dollar invested.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 54 / 100
Financial Health Score 54/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of James Hardie's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
76

James Hardie has an operating margin of 9.3%, meaning the company retains $9 of operating profit per $100 of revenue. This strong profitability earns a score of 76/100, reflecting efficient cost management and pricing power. This is down from 16.9% the prior year.

Growth
67

James Hardie's revenue surged 24.7% year-over-year to $4.8B, reflecting rapid business expansion. This strong growth earns a score of 67/100.

Leverage
13

James Hardie has elevated debt relative to equity (D/E of 0.70), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 13/100, reflecting increased financial risk.

Liquidity
44

James Hardie's current ratio of 1.58 indicates adequate short-term liquidity, earning a score of 44/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
58

James Hardie has a free cash flow margin of 4.3%, earning a moderate score of 58/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
66

James Hardie earns a strong 1.6% return on equity (ROE), meaning it generates $2 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 66/100. This is down from 19.6% the prior year.

Altman Z-Score Grey Zone
2.17

James Hardie scores 2.17, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($17.7B) relative to total liabilities ($7.3B). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak
3/9

James Hardie passes 3 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Cash-Backed
5.67x

For every $1 of reported earnings, James Hardie generates $5.67 in operating cash flow ($589.8M OCF vs $104.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk
1.94x

James Hardie earns $1.94 in operating income for every $1 of interest expense ($447.6M vs $231.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$4.8B
YoY+24.7%
5Y CAGR+10.7%
10Y CAGR+10.8%

James Hardie generated $4.8B in revenue in fiscal year 2026. This represents an increase of 24.7% from the prior year.

EBITDA
$941.1M
YoY+7.9%
5Y CAGR+9.1%
10Y CAGR+8.1%

James Hardie's EBITDA was $941.1M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 7.9% from the prior year.

Net Income
$104.0M
YoY-75.5%
5Y CAGR-16.9%
10Y CAGR-8.2%

James Hardie reported $104.0M in net income in fiscal year 2026. This represents a decrease of 75.5% from the prior year.

EPS (Diluted)
$0.19
YoY-80.6%
5Y CAGR-20.3%
10Y CAGR-10.1%

James Hardie earned $0.19 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 80.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$205.9M
YoY-45.9%
5Y CAGR-21.2%
10Y CAGR+1.0%

James Hardie generated $205.9M in free cash flow in fiscal year 2026, representing cash available after capex. This represents a decrease of 45.9% from the prior year.

Cash & Debt
$269.2M
YoY-52.2%
5Y CAGR+5.2%
10Y CAGR+9.7%

James Hardie held $269.2M in cash against $4.5B in long-term debt as of fiscal year 2026.

Shares Outstanding
580M
YoY+35.0%
5Y CAGR+5.5%
10Y CAGR+2.7%

James Hardie had 580M shares outstanding in fiscal year 2026. This represents an increase of 35.0% from the prior year.

Dividends Per Share

Not reported for fiscal year 2026.

Margins & Returns

Gross Margin
35.8%
YoY-3.0pp
5Y CAGR-0.4pp
10Y CAGR-0.8pp

James Hardie's gross margin was 35.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 3.0 percentage points from the prior year.

Operating Margin
9.3%
YoY-7.7pp
5Y CAGR-7.0pp
10Y CAGR-11.2pp

James Hardie's operating margin was 9.3% in fiscal year 2026, reflecting core business profitability. This is down 7.7 percentage points from the prior year.

Net Margin
2.1%
YoY-8.8pp
5Y CAGR-6.9pp
10Y CAGR-12.0pp

James Hardie's net profit margin was 2.1% in fiscal year 2026, showing the share of revenue converted to profit. This is down 8.8 percentage points from the prior year.

Return on Equity
1.6%
YoY-18.0pp
5Y CAGR-23.2pp

James Hardie's ROE was 1.6% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is down 18.0 percentage points from the prior year.

Capital Allocation

R&D Spending
$60.7M
YoY+25.2%
5Y CAGR+12.1%
10Y CAGR+7.5%

James Hardie invested $60.7M in research and development in fiscal year 2026. This represents an increase of 25.2% from the prior year.

Share Buybacks
$0
YoY-100.0%

James Hardie repurchased no shares in fiscal year 2026. This represents a decrease of 100.0% from the prior year.

Capital Expenditures
$383.9M
YoY-9.1%
5Y CAGR+28.2%
10Y CAGR+18.0%

James Hardie invested $383.9M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 9.1% from the prior year.

JHX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

JHX annual income statement
MetricFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Revenue$4.8B+24.7%$3.9B-1.5%$3.9B+4.2%$3.8B+4.5%$3.6B+24.3%$2.9B+11.6%$2.6B+4.0%$2.5B+22.0%$2.1B+6.9%$1.9B+11.2%$1.7B+4.3%$1.7B+10.9%$1.5B+13.1%$1.3B+6.8%$1.2B
Cost of Revenue$3.1B+30.9%$2.4B+1.0%$2.3B-4.8%$2.5B+7.1%$2.3B+23.9%$1.9B+11.0%$1.7B-0.1%$1.7B+26.5%$1.3B+6.2%$1.2B+13.8%$1.1B+1.7%$1.1B+9.2%$987.4M+9.5%$902.0M+8.6%$830.5M
Gross Profit$1.7B+14.9%$1.5B-5.3%$1.6B+21.1%$1.3B-0.1%$1.3B+24.9%$1.1B+12.6%$933.7M+12.4%$831.0M+13.8%$730.2M+8.2%$674.7M+6.7%$632.2M+9.2%$578.8M+14.3%$506.4M+20.8%$419.3M+3.0%$407.0M
R&D Expenses$60.7M+25.2%$48.5M+3.2%$47.0M+18.7%$39.6M+4.2%$38.0M+10.8%$34.3M+4.6%$32.8M-13.5%$37.9M+13.8%$33.3M+9.9%$30.3M+2.7%$29.5M-6.9%$31.7M-4.2%$33.1M-11.0%$37.2M+22.4%$30.4M
SG&A Expenses$946.4M+58.7%$596.2M-1.0%$602.2M+21.9%$494.0M+7.1%$461.2M+18.4%$389.6M-6.3%$415.8M+3.0%$403.6M+29.6%$311.3M+6.8%$291.6M+14.7%$254.2M+3.5%$245.5M+9.4%$224.4M+2.7%$218.6M+14.5%$191.0M
Operating Income$447.6M-31.8%$655.9M-14.5%$767.4M+3.5%$741.4M+8.6%$682.6M+44.4%$472.8M+38.0%$342.5M-2.6%$351.6M+53.4%$229.2M-41.7%$393.2M+11.1%$354.0M+5.7%$335.0M+530.9%$53.1M+80.0%$29.5M-81.0%$155.5M
Interest Expense$231.1M+2143.7%$10.3M-32.7%$15.3M-50.2%$30.7M-21.9%$39.3MN/A$57.5M+6.1%$54.2M+64.7%$32.9M+15.4%$28.5M+7.1%$26.6M+171.4%$9.8M+117.8%$4.5M-18.2%$5.5M-50.9%$11.2M
Income Tax$102.7M-53.6%$221.4M-9.5%$244.6M+15.7%$211.5M+14.9%$184.0M+23.3%$149.2M+220.9%$46.5M-35.2%$71.8M+154.6%$28.2M-68.8%$90.5M+5.1%$86.1M+175.1%$31.3M+169.7%-$44.9M-280.5%-$11.8M+97.4%-$453.2M
Net Income$104.0M-75.5%$424.0M-16.9%$510.2M-0.4%$512.0M+11.5%$459.1M+74.7%$262.8M+8.8%$241.5M+5.6%$228.8M+56.6%$146.1M-47.2%$276.5M+13.1%$244.4M-16.1%$291.3M+192.8%$99.5M+118.7%$45.5M-92.5%$604.3M
EPS (Diluted)$0.19-80.6%$0.98-15.5%$1.16+0.9%$1.15+11.7%$1.03+74.6%$0.59+9.3%$0.54+3.8%$0.52+57.6%$0.33-46.8%$0.62+12.7%$0.55-15.4%$0.65+195.5%$0.22+120.0%$0.10-92.8%$1.38

JHX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

JHX annual balance sheet
MetricFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Total Assets$13.7B+161.7%$5.2B+6.5%$4.9B+9.7%$4.5B+5.6%$4.2B+3.8%$4.1B+1.5%$4.0B-0.1%$4.0B+71.5%$2.4B+16.8%$2.0B-0.8%$2.0B-0.7%$2.0B-2.8%$2.1B-0.4%$2.1B-8.5%$2.3B
Current Assets$1.8B+7.3%$1.7B+19.1%$1.4B+32.9%$1.1B-4.4%$1.1B+19.1%$943.6M+3.9%$908.4M+20.5%$754.1M-10.5%$842.6M+33.3%$632.1M+18.3%$534.3M+2.0%$524.0M-20.5%$659.1M-5.4%$696.6M-19.6%$866.4M
Cash & Equivalents$269.2M-52.2%$562.7M+54.2%$365.0M+223.0%$113.0M-9.6%$125.0M-40.0%$208.5M+44.4%$144.4M+83.5%$78.7M-72.1%$281.6M+256.9%$78.9M-26.3%$107.1M+59.9%$67.0M-60.0%$167.5M+9.0%$153.7M-42.1%$265.4M
Inventory$635.7M+83.1%$347.1M+2.8%$337.8M-1.9%$344.2M+23.1%$279.7M+28.1%$218.3M-28.4%$305.1M-3.9%$317.4M+24.1%$255.7M+26.0%$202.9M+5.1%$193.0M-11.5%$218.0M+16.9%$186.5M+8.4%$172.1M-4.3%$179.8M
Goodwill$4.8B+2367.9%$193.7M+0.6%$192.6M-1.2%$194.9M-2.3%$199.5M-4.7%$209.3M+6.3%$196.9M-2.1%$201.1M+4004.1%$4.9MN/AN/AN/AN/AN/AN/A
Total Liabilities$7.3B+136.7%$3.1B+0.5%$3.1B+6.5%$2.9B-1.5%$2.9B-3.9%$3.0B+1.2%$3.0B-2.1%$3.1B+18.9%$2.6B+15.6%$2.2B-1.3%$2.3B+0.3%$2.2B-2.4%$2.3B+9.9%$2.1B-4.1%$2.2B
Current Liabilities$1.2B+42.9%$810.2M+1.6%$797.7M+14.4%$697.3M-9.4%$769.9M-14.6%$901.1M+76.7%$510.0M+5.6%$483.0M+22.4%$394.6M-8.0%$428.8M+7.3%$399.8M+5.8%$377.9M-30.2%$541.3M+67.6%$322.9M-19.9%$403.1M
Long-Term Debt$4.5B+304.6%$1.1B-0.4%$1.1B+5.3%$1.1B+20.7%$877.3M+2.2%$858.6M-36.6%$1.4B-1.9%$1.4B+56.1%$884.4M+56.7%$564.5M+12.5%$501.8M+26.2%$397.5MN/AN/AN/A
Total Equity$6.4B+197.3%$2.2B+16.3%$1.9B+15.4%$1.6B+20.9%$1.3B+25.7%$1.1B+2.5%$1.0B+6.3%$974.4M+539.9%-$221.5M-4.4%-$212.2M+5.8%-$225.2M-11.2%-$202.6M-1.8%-$199.0M-1193.4%$18.2M-85.6%$126.4M
Retained Earnings$1.8B+6.0%$1.7B+19.3%$1.4B+20.8%$1.2B+34.1%$892.4M+46.0%$611.4M-7.3%$659.5M+14.3%$577.1M+190.8%-$635.3M-3.7%-$612.9M+1.4%-$621.8M-6.0%-$586.6M+2.6%-$602.4M-68.5%-$357.6M-66.6%-$214.6M

Not reported in any period shown, so not listed: Accounts Receivable.

JHX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

JHX annual cash flow statement
MetricFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Operating Cash Flow$589.8M-26.5%$802.8M-12.2%$914.2M+50.5%$607.6M-19.8%$757.2M-3.8%$786.9M+74.4%$451.2M+48.4%$304.0M-1.5%$308.5M-19.3%$382.5M+46.9%$260.4M+45.1%$179.5M-44.4%$322.8M+195.3%$109.3M-71.8%$387.2M
Capital Expenditures$383.9M-9.1%$422.2M-6.0%$449.3M-24.0%$591.3M+129.4%$257.8M+132.9%$110.7M-42.9%$193.8M-39.0%$317.5M+51.0%$210.2M+106.3%$101.9M+39.2%$73.2M-73.5%$276.2M+139.3%$115.4M+88.9%$61.1M+70.7%$35.8M
Free Cash Flow$205.9M-45.9%$380.6M-18.1%$464.9M+2752.1%$16.3M-96.7%$499.4M-26.1%$676.2M+162.7%$257.4M+2006.7%-$13.5M-113.7%$98.3M-65.0%$280.6M+49.9%$187.2M+293.6%-$96.7M-146.6%$207.4M+330.3%$48.2M-86.3%$351.4M
Investing Cash Flow-$4.2B-842.1%-$446.7M+5.1%-$470.5M+28.7%-$660.1M-89.6%-$348.2M-189.2%-$120.4M+40.9%-$203.8M+76.4%-$864.4M-252.1%-$245.5MN/AN/AN/A-$118.8M-99.0%-$59.7M-19.6%-$49.9M
Financing Cash Flow$3.4B+2119.8%-$165.9M+21.0%-$210.1M-727.2%-$25.4M+94.4%-$449.6M+16.8%-$540.2M-201.8%-$179.0M-149.1%$364.2M+501.0%$60.6MN/AN/AN/A-$186.3M-17.4%-$158.7M-88.0%-$84.4M
Dividends PaidN/A$0$0-100.0%$129.6M-73.2%$484.0M$0-100.0%$158.6M-7.8%$172.1M-3.0%$177.5M+0.4%$176.8M-28.3%$246.5M-36.8%$390.1M+95.9%$199.1M+5.6%$188.5M+983.3%$17.4M
Share Buybacks$0-100.0%$149.9M-44.8%$271.4M+246.2%$78.4M$0$0N/A$0$0-100.0%$99.8M+347.5%$22.3M+145.1%$9.1M-58.8%$22.1MN/A$19.0M

JHX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

JHX annual financial ratios
MetricFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Gross Margin35.8%-3.0pp38.8%-1.5pp40.4%+5.6pp34.7%-1.6pp36.3%+0.2pp36.2%+0.3pp35.8%+2.7pp33.1%-2.4pp35.5%+0.4pp35.1%-1.5pp36.6%+1.7pp34.9%+1.0pp33.9%+2.2pp31.7%-1.2pp32.9%
Operating Margin9.3%-7.7pp16.9%-2.6pp19.5%-0.1pp19.6%+0.8pp18.9%+2.6pp16.3%+3.1pp13.1%-0.9pp14.0%+2.9pp11.2%-9.3pp20.5%0.0pp20.5%+0.3pp20.2%+16.7pp3.5%+1.3pp2.2%-10.3pp12.6%
Net Margin2.1%-8.8pp10.9%-2.0pp13.0%-0.6pp13.6%+0.9pp12.7%+3.7pp9.0%-0.2pp9.3%+0.1pp9.1%+2.0pp7.1%-7.3pp14.4%+0.3pp14.1%-3.4pp17.6%+10.9pp6.7%+3.2pp3.4%-45.4pp48.8%
Return on Equity1.6%-18.0pp19.6%-7.8pp27.5%-4.3pp31.8%-2.7pp34.4%+9.7pp24.8%+1.4pp23.3%-0.2pp23.5%N/AN/AN/AN/AN/A250.0%-228.1pp478.1%
Return on Assets0.8%-7.4pp8.1%-2.3pp10.4%-1.0pp11.4%+0.6pp10.8%+4.4pp6.4%+0.4pp6.0%+0.3pp5.7%-0.5pp6.2%-7.5pp13.7%+1.7pp12.0%-2.2pp14.2%+9.5pp4.7%+2.6pp2.1%-24.0pp26.2%
Current Ratio1.58-0.5x2.10+0.3x1.79+0.2x1.54+0.1x1.46+0.4x1.05-0.7x1.78+0.2x1.56-0.6x2.14+0.7x1.47+0.1x1.34-0.1x1.39+0.2x1.22-0.9x2.160.0x2.15
Debt-to-Equity0.70+0.2x0.51-0.1x0.60-0.1x0.660.0x0.66-0.2x0.81-0.5x1.31-0.1x1.42N/AN/AN/AN/AN/A115.11+97.8x17.28
FCF Margin4.3%-5.6pp9.8%-2.0pp11.8%+11.4pp0.4%-13.4pp13.8%-9.4pp23.3%+13.4pp9.9%+10.4pp-0.5%-5.3pp4.8%-9.8pp14.6%+3.8pp10.8%+16.7pp-5.8%-19.7pp13.9%+10.2pp3.6%-24.7pp28.4%

Similar Companies

Frequently Asked Questions

What is James Hardie's annual revenue?

James Hardie (JHX) reported $4.8B in total revenue for fiscal year 2026. This represents a 24.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is James Hardie's revenue growing?

James Hardie (JHX) revenue grew by 24.7% year-over-year, from $3.9B to $4.8B in fiscal year 2026.

Is James Hardie profitable?

Yes, James Hardie (JHX) reported a net income of $104.0M in fiscal year 2026, with a net profit margin of 2.1%.

James Hardie (JHX) reported diluted earnings per share of $0.19 for fiscal year 2026. This represents a -80.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

James Hardie (JHX) had EBITDA of $941.1M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, James Hardie (JHX) had $269.2M in cash and equivalents against $4.5B in long-term debt.

James Hardie (JHX) had a gross margin of 35.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

James Hardie (JHX) had an operating margin of 9.3% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

James Hardie (JHX) had a net profit margin of 2.1% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

James Hardie (JHX) has a return on equity of 1.6% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

James Hardie (JHX) generated $205.9M in free cash flow during fiscal year 2026. This represents a -45.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

James Hardie (JHX) generated $589.8M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

James Hardie (JHX) had $13.7B in total assets as of fiscal year 2026, including both current and long-term assets.

James Hardie (JHX) invested $383.9M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

James Hardie (JHX) invested $60.7M in research and development during fiscal year 2026.

James Hardie (JHX) had 580M shares outstanding as of fiscal year 2026.

James Hardie (JHX) had a current ratio of 1.58 as of fiscal year 2026, which is generally considered healthy.

James Hardie (JHX) had a debt-to-equity ratio of 0.70 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

James Hardie (JHX) had a return on assets of 0.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

James Hardie (JHX) has an Altman Z-Score of 2.17, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

James Hardie (JHX) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

James Hardie (JHX) has an earnings quality ratio of 5.67x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

James Hardie (JHX) has an interest coverage ratio of 1.94x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

James Hardie (JHX) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top